Table of Contents
ToggleCompany Overview
Zenith Drugs is a pharmaceutical manufacturing and trading company based out of Indore.
We are specialized in manufacturing high-quality and affordable Medicines to support our patients in need. Our Company is also into Generic Medicines and Generic Medicines are cost effective. Since its inception, our company has focused on building a strong foundation and laying the groundwork for our future growth and success. With dedication and strategic planning, we managed to establish a reputable presence in the pharmaceutical industry.
The Company was incorporated with the objective of better service deliverance in the field of medicine and being a better premium pharmaceutical company in India and abroad for cost-effective human medicine. Our Company always emphasizes core strengths and policies that focus on technology and great deliverance. With a passion for setting high standards of services, the company has always taken all measures to scale up as and when required only to deliver the best. We work diligently and have a wide range of products to cater to every need and to reach the client’s sensitivity and centricity.
We are proud to be WHO-GMP compliant, adhering to the stringent guidelines set by the World Health Organization.
1. ORS Powder;
2. Liquid Orals;
3. Ointments;
4. Liquid Externals; and
5. Capsules.
Our Company has a Certificate of Good Manufacturing Practices issued by the Office of the Controller, Food and Drugs Administration, Madhya Pradesh, Idgah Hills, Bhopal, Madhya Pradesh. The quality standards of our Company are based on adherence to Good Manufacturing Practices (GMP) guidelines, regulatory requirements, and internal quality control processes. The Company is constantly required to adhere to the same. These measures are implemented to ensure the highest level of quality in our manufacturing operations.
ZENITH DRUGS LIMITED IPO DATE & PRICE BAND DETAILS
IPO Open Date February 19, 2024 IPO Close Date February 22, 2024 IPO Size Approx ₹40.68 Crores IPO Face Value ₹10 Per Equity Share IPO Price Band ₹75 to ₹79 Per Every Share IPO Listing On NSE and BSE IPO Retail Quota 35% IPO QIB Quota 50% IPO NII Quota 15%
ZENITH DRUGS LIMITED IPO MARKET LOT DETAILS
Application Lot Size Shares Amount Retail Minimum 1 1600 ₹126,400 Retail Maximum 1 1600 ₹126,400 S-HNI Minimum 2 3200 ₹2,52,800
OBJECTS OF THE ISSUE
- Purchase of Machinery & Equipments for Setting up New Unit.
- Existing Manufacturing Block Upgradation.
- Working Capital Requirements.
- General Corporate Purposes.
ZENITH DRUGS LIMITED IPO ALLOTMENT & LISTING DATE (DETAILS)
IPO Open Date Feb 19, 2024 IPO Close Date Feb 22, 2024 Basis of Allotment Feb 23, 2024 Refunds Feb 26, 2024 Credit to Demat Account Feb 26, 2024 IPO Listing Date Feb 27, 2024
ZENITH DRUGS LIMITED FINANCIAL REPORTS
₹ in Crores Year Revenue Expense PAT 2023 ₹115.70 ₹104.85 ₹5.15 2022 ₹92.67 ₹84.82 ₹3.13 2021 ₹73.53 ₹66.37 ₹3.03
OUR PROMOTERS
The Promoters of our Company are –
- Mr. Sandeep Bhardwaj
- Mr. Bhupesh Soni
- Mr. Ajay Singh Dassundi.
Qualitative Factors:-
Some of the qualitative factors, which form the basis for the Issue Price, are:
- Experienced Promoters and Management Team
- Cost Efficiency
- Formulation & Development
- Regulatory Compliance
- Global Reach
- Product Portfolio
- Supply Chain Efficiency
- Scalable Business Model
- Strong sales, marketing, and distribution capabilities
Basic & Diluted Earnings Per Equity Share (“EPS”)
Financial Year Ended Basic EPS (in ₹) Diluted EPS (in ₹) Weight March 31, 2023 75.73 75.73 3 March 31, 2022 78.46 78.46 2 March 31, 2021 128.83 128.83 1 Weighted Average 103.19 103.19
ZENITH DRUGS LIMITED COMPANY CONTACT DETAILS
K. No. 72 / 5, Village Muradpura,
NA, Depalpur, Indore-453001,
Madhya Pradesh, India.
Tel: +91 84355 01867
Email: info@zenithdrugs.com
Website: www.zenithdrugs.com
ZENITH DRUGS LIMITED IPO REGISTAR
Bigshare Services Private Limited
Office No S6-2, 6th Floor, Pinnacle Business Park
Next to Ahura Centre, Mahakali Caves Road, Andheri
(East), Mumbai –400093.
Tel.:+91 22 6263 8200
Contact Person: Jibu John
Email: ipo@bigshareonline.com
Website:www.bigshareonline.com